Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2007-005246-20-DK
EUCTR2007-005246-20-DK
Active, not recruiting
Phase 1

Amiodarone prophylaxis for atrial fibrillation in patients undergoing surgery for lung cancer: A controlled, randomized, double blinded trial. - PASCART

Aarhus University Hospital, Skejby0 sites275 target enrollmentFebruary 15, 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAtrial fibrillation after lung resection due to cancer in the lungMedDRA version: 9.1Level: LLTClassification code 10003658Term: Atrial fibrillationMedDRA version: 9.1Level: LLTClassification code 10025065Term: Lung carcinoma cell type unspecified recurrent
DrugsCordarone

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Atrial fibrillation after lung resection due to cancer in the lung
Sponsor
Aarhus University Hospital, Skejby
Enrollment
275
Status
Active, not recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 15, 2008
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Aarhus University Hospital, Skejby

Eligibility Criteria

Inclusion Criteria

  • •1\) Enlisted for lungresection due to pulmonary neoplasma
  • •2\) Elective surgery
  • •3\) Willingness of randomisation
  • •4\) Above 18 years
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •1\) Former pulmonary surgery performed
  • •2\) Former heart surgery
  • •3\) Resting heart beat below 40 beats/ min
  • •4\) AV\-blockage of any degree
  • •5\) Paroxysmal, persistent or permanent atrial fibrillation or flutter
  • •6\) Former insidence of paroxysmal, persistent or permanent atrial fibrillation or flutter
  • •7\) Pregnant
  • •8\) Breastfeeding
  • •9\) Allergy towards the substances in cordarone

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
Prevention of Atrial Fibrillation Following Noncardiac Thoracic SurgeryAtrial Fibrillation
NCT00127712Indiana University130
Active, not recruiting
Not Applicable
PREvention of atrial fibrillation in patientS undergoing thorAcic surGEry for lung cance - PRESAGElung cancer patients undergoing thoracic surgeryMedDRA version: 9.1Level: LLTClassification code 10026532Term: Malignant neoplasm of thorax
EUCTR2007-003856-12-ITISTITUTO EUROPEO DI ONCOLOGIA
Completed
Not Applicable
The efficacy of Landiolol Administration for Prevention of Atrial Fibrillation after Proximal Aortic Surgerythe aneurysm of aortic root, ascending aorta, or aortic arch/the dissection of proximal aorta
JPRN-UMIN000043692Hiroshima city hospital264
Completed
Phase 4
Prevention of Atrial Fibrillation Following EsophagectomyAtrial FibrillationEsophagectomy
NCT00420017Indiana University80
Completed
Not Applicable
?Effect of Dronedarone on prevention of atrial fibrilatioAtrial Fibrillation.Atrial fibrillation and flutter
IRCT201202011965N2Vice chancellor for research, Tehran University of Medical Sciences100